ARCHIVES

Pfizer Begins Phase III Trial Of Sunitinib In NSCLC

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: FASEB Letter urges Support Of NIH, NSF; Kansas Recruits Experts From Washington State

July 30, 1993

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

In Brief: UICC Publishes International directory Of Cancer Centers; HSAs Still Worry NCI

January 7, 1977

Avastin Regimen Bested Chemo Alone In Early Disease

January 31, 2003

Long-Term Results Find Cisplatin Improves Survival

May 25, 2007

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979